These include an antisense approach (Gorin et al. 2005) and the use of pharmacological inhibitors (Sedeek et al. 2010), both studies indicating that decreased Nox4 activation confers renal benefits in the setting of experimental diabetes. Here, NOX4 is linked to diabetes mellitus.